Viewing Study NCT00483561


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-05-28 @ 1:25 AM
Study NCT ID: NCT00483561
Status: TERMINATED
Last Update Posted: 2023-09-13
First Post: 2007-06-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy
Sponsor: University of Nebraska
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the prostate View
None recurrent prostate cancer View
None stage III prostate cancer View
None stage IV prostate cancer View